Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Molecular Partners AG MOLN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • CH • USD

SharesGrow Score
52/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.00
+209.5%

MOLN Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value

No ownership data available for MOLN.

People Also View

OPT
OPT
Opthea Limited
$3.41
+1.49%
 EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.70
+1.63%
 MLYS
MLYS
Mineralys Therapeutics, Inc.
$30.42
+11.35%
 PHVS
PHVS
Pharvaris N.V.
$29.14
+1.60%
 GLUE
GLUE
Monte Rosa Therapeutics, Inc.
$18.23
+4.17%
 TRDA
TRDA
Entrada Therapeutics, Inc.
$13.99
-0.29%
 VIGL
VIGL
Vigil Neuroscience, Inc.
$8.05
+0.00%
 RZLT
RZLT
Rezolute, Inc.
$3.59
+1.13%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message